How to appeal an Elevance Health specialty biologics denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Elevance Health-specific note: Operates Anthem BCBS in 14 states. Owns Carelon (formerly AIM) which manages utilization for specialty drugs and advanced imaging. State complaint route is to the state insurance department where the policy was issued.

What Elevance Health's policy requires for specialty biologics

Cited policy: Anthem/Elevance Clinical UM Guideline clinical guideline - Adalimumab and Biosimilars

Moderate-severe disease + conventional therapy failure + TB/Hep B/C screening. Most BCBS plans now require biosimilar adalimumab first (2024-2026 adoption wave).

How Elevance Health denies specialty biologics — and how to counter it

Where Elevance Health pushes back: 1) Drug non-formulary; 2) Step therapy: failure of two preferred TNFi biosimilars required; 3) Lab work older than 12 months; 4) Missing rheumatologist/dermatologist/gastroenterologist attestation.

Counter-arguments that hold up: Identify the specific BCBS subsidiary and cite its named policy by number — generic appeals are weaker. For BCBS FEP: governed by FEHB; appeals to OPM after internal exhaustion (5 CFR 890.105). State external review under NAIC Model Act timelines. For self-funded ERISA BCBS plans: demand full claim file under 29 CFR 2560.503-1(h)(2)(iii).

What Elevance Health typically denies for specialty biologics

Across Elevance Health's commercial and Medicare books, denials cluster around a small number of patterns. For specialty biologics, expect:

• Step therapy
• Medical necessity for biologics
• Out-of-network for behavioral health
• Bariatric surgery prior auth

Treatments most often denied in this category

These are the specialty biologics treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Humira
• Enbrel
• Remicade
• Stelara
• Skyrizi
• Cosentyx

How to submit the appeal to Elevance Health

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Elevance Health cited in the denial.
3. File the appeal through Elevance Health's portal (members: https://www.anthem.com ; providers: https://providers.anthem.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In IN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Elevance Health's prior-authorization criteria by drug: Elevance Health PA criteria on ApprovalHelp.